Citisurg Hospicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.24 M
- Satisfied Charges ₹ 1.90 M
- Revenue Growth 48.63%
- Profit Growth 77.33%
- Ebitda 541.35%
- Net Worth 46.05%
- Total Assets 235.29%
About Citisurg Hospicare
Citisurg Hospicare Private Limited (CHPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 March 2019 (Five years and ten months 17 days old ). Its registered office is in Yamuna Nagar, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.24 M. The company has closed loans amounting to ₹1.90 M, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Saini and Sunita Saini serve as directors at the Company.
Company Details
-
Location
Yamuna Nagar, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U93000HR2019PTC079423
-
Company No.
079423
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Mar 2019
-
Date of AGM
20 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Citisurg Hospicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Saini
|
Director | 29-Mar-2019 | Current |
|
Sunita Saini
|
Director | 29-Mar-2019 | Current |
Financial Performance of Citisurg Hospicare.
Citisurg Hospicare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.63% increase. The company also saw a substantial improvement in profitability, with a 77.33% increase in profit. The company's net worth Soared by an impressive increase of 46.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Citisurg Hospicare?
Unlock access to Citisurg Hospicare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.24 M
₹1.90 M
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2023 | Others | ₹1.24 M | Open |
| 17 Mar 2022 | Others | ₹1.90 M | Satisfied |
How Many Employees Work at Citisurg Hospicare?
Citisurg Hospicare has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Citisurg Hospicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Citisurg Hospicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.